These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 34111505)

  • 1. An antibody engineering platform using amino acid networks: A case study in development of antiviral therapeutics.
    Lee DCP; Raman R; Ghafar NA; Budigi Y
    Antiviral Res; 2021 Aug; 192():105105. PubMed ID: 34111505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rational Engineering and Characterization of an mAb that Neutralizes Zika Virus by Targeting a Mutationally Constrained Quaternary Epitope.
    Tharakaraman K; Watanabe S; Chan KR; Huan J; Subramanian V; Chionh YH; Raguram A; Quinlan D; McBee M; Ong EZ; Gan ES; Tan HC; Tyagi A; Bhushan S; Lescar J; Vasudevan SG; Ooi EE; Sasisekharan R
    Cell Host Microbe; 2018 May; 23(5):618-627.e6. PubMed ID: 29746833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computational design of protein antigens that interact with the CDR H3 loop of HIV broadly neutralizing antibody 2F5.
    Azoitei ML; Ban YA; Kalyuzhny O; Guenaga J; Schroeter A; Porter J; Wyatt R; Schief WR
    Proteins; 2014 Oct; 82(10):2770-82. PubMed ID: 25043744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. De novo design of antibody complementarity determining regions binding a FLAG tetra-peptide.
    Entzminger KC; Hyun JM; Pantazes RJ; Patterson-Orazem AC; Qerqez AN; Frye ZP; Hughes RA; Ellington AD; Lieberman RL; Maranas CD; Maynard JA
    Sci Rep; 2017 Aug; 7(1):10295. PubMed ID: 28860479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineering a high-affinity anti-IL-15 antibody: crystal structure reveals an α-helix in VH CDR3 as key component of paratope.
    Lowe DC; Gerhardt S; Ward A; Hargreaves D; Anderson M; Ferraro F; Pauptit RA; Pattison DV; Buchanan C; Popovic B; Finch DK; Wilkinson T; Sleeman M; Vaughan TJ; Mallinder PR
    J Mol Biol; 2011 Feb; 406(1):160-75. PubMed ID: 21167836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A germline knowledge based computational approach for determining antibody complementarity determining regions.
    Zhao S; Lu J
    Mol Immunol; 2010 Jan; 47(4):694-700. PubMed ID: 19939452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody humanization by redesign of complementarity-determining region residues proximate to the acceptor framework.
    Hanf KJ; Arndt JW; Chen LL; Jarpe M; Boriack-Sjodin PA; Li Y; van Vlijmen HW; Pepinsky RB; Simon KJ; Lugovskoy A
    Methods; 2014 Jan; 65(1):68-76. PubMed ID: 23816785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A universal combinatorial design of antibody framework to graft distinct CDR sequences: a bioinformatics approach.
    Haidar JN; Yuan QA; Zeng L; Snavely M; Luna X; Zhang H; Zhu W; Ludwig DL; Zhu Z
    Proteins; 2012 Mar; 80(3):896-912. PubMed ID: 22180101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homology Modeling of Antibody Variable Regions: Methods and Applications.
    Bansia H; Ramakumar S
    Methods Mol Biol; 2023; 2627():301-319. PubMed ID: 36959454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural Insights into Reovirus σ1 Interactions with Two Neutralizing Antibodies.
    Dietrich MH; Ogden KM; Katen SP; Reiss K; Sutherland DM; Carnahan RH; Goff M; Cooper T; Dermody TS; Stehle T
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27928010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RosettaAntibodyDesign (RAbD): A general framework for computational antibody design.
    Adolf-Bryfogle J; Kalyuzhniy O; Kubitz M; Weitzner BD; Hu X; Adachi Y; Schief WR; Dunbrack RL
    PLoS Comput Biol; 2018 Apr; 14(4):e1006112. PubMed ID: 29702641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humanization of a murine monoclonal antibody by simultaneous optimization of framework and CDR residues.
    Wu H; Nie Y; Huse WD; Watkins JD
    J Mol Biol; 1999 Nov; 294(1):151-62. PubMed ID: 10556035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonneutralizing human antibody fragments against hepatitis C virus E2 glycoprotein modulate neutralization of binding activity of human recombinant Fabs.
    Burioni R; Bugli F; Mancini N; Rosa D; Di Campli C; Moroncini G; Manzin A; Abrignani S; Varaldo PE; Clementi M; Fadda G
    Virology; 2001 Sep; 288(1):29-35. PubMed ID: 11543655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of antibody numbering systems in the development of antibody engineering.
    Patel R; Verma P; Nagraj AK; Gavade A; Sharma OP; Patil J
    Hum Antibodies; 2023; 31(4):71-80. PubMed ID: 38217590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Characterization of Two Monoclonal Antibodies against the Same Epitope on B-Cell Receptor Associated Protein 31.
    Kim WT; Shin S; Hwang HJ; Kim MK; Jung HS; Park H; Ryu CJ
    PLoS One; 2016; 11(12):e0167527. PubMed ID: 27907150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induced pocket to accommodate the cell attachment Arg-Gly-Asp motif in a neutralizing antibody against foot-and-mouth-disease virus.
    Verdaguer N; Mateu MG; Bravo J; Domingo E; Fita I
    J Mol Biol; 1996 Feb; 256(2):364-76. PubMed ID: 8594203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural mimicry of CD4 by a cross-reactive HIV-1 neutralizing antibody with CDR-H2 and H3 containing unique motifs.
    Prabakaran P; Gan J; Wu YQ; Zhang MY; Dimitrov DS; Ji X
    J Mol Biol; 2006 Mar; 357(1):82-99. PubMed ID: 16426633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The human combinatorial antibody library HuCAL GOLD combines diversification of all six CDRs according to the natural immune system with a novel display method for efficient selection of high-affinity antibodies.
    Rothe C; Urlinger S; Löhning C; Prassler J; Stark Y; Jäger U; Hubner B; Bardroff M; Pradel I; Boss M; Bittlingmaier R; Bataa T; Frisch C; Brocks B; Honegger A; Urban M
    J Mol Biol; 2008 Feb; 376(4):1182-200. PubMed ID: 18191144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-affinity human antibodies from phage-displayed synthetic Fab libraries with a single framework scaffold.
    Lee CV; Liang WC; Dennis MS; Eigenbrot C; Sidhu SS; Fuh G
    J Mol Biol; 2004 Jul; 340(5):1073-93. PubMed ID: 15236968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural and genetic basis for development of broadly neutralizing influenza antibodies.
    Lingwood D; McTamney PM; Yassine HM; Whittle JR; Guo X; Boyington JC; Wei CJ; Nabel GJ
    Nature; 2012 Sep; 489(7417):566-70. PubMed ID: 22932267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.